FP-0522

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFP-0522
Drug Alias NameAdenosine A3 antagonist (Faust)FP-0522
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A3 receptor antagonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsGlaucomaPulmonary Disease, Chronic ObstructiveAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsGlaucomaPulmonary Disease, Chronic ObstructiveAsthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A